In addition, 3OBA treatment attenuated sepsis-induced liver and kidney EBD penetration (Fig. 7, B and C), suggesting that inhibition of GPR81/lactate signaling improves vascular permeability after sepsis. The gene discussed is HCAR1; the disease is Sepsis.